Cargando…
DNA methylation/hydroxymethylation in melanoma
Melanoma is a malignant tumor of melanocytes and is considered to be the most aggressive cancer among all skin diseases. The pathogenesis of melanoma has not been well documented, which may restrict the research and development of biomarkers and therapies. To date, several genetic and epigenetic fac...
Autores principales: | Fu, Siqi, Wu, Haijing, Zhang, Huiming, Lian, Christine G., Lu, Qianjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652847/ https://www.ncbi.nlm.nih.gov/pubmed/29100458 http://dx.doi.org/10.18632/oncotarget.18293 |
Ejemplares similares
-
Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus
por: Wu, Haijing, et al.
Publicado: (2016) -
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2012) -
MLML: consistent simultaneous estimates of DNA methylation and hydroxymethylation
por: Qu, Jianghan, et al.
Publicado: (2013) -
Quantifying propagation of DNA methylation and hydroxymethylation with iDEMS
por: Stewart-Morgan, Kathleen R., et al.
Publicado: (2023) -
Hydroxymethylation of DNA: an epigenetic marker
por: Richa, Rajneesh, et al.
Publicado: (2014)